We assessed exposure to dioxin-like compounds using chemical and bioassay analysis in different matrices in a female population. A total of 106 serum and 9 follicular fluid samples were collected from infertile women attending Centers for Reproductive Medicine in Belgium from 1996 to 1998. Major polychlorinated biphenyl (PCB) congeners were quantified by chemical analysis using gas chromatography with electron-capture detection, and the chemical-activated luciferase gene expression (CALUX) bioassay was used to determine the total dioxin-like toxic equivalence (TEQ) of m ixu of polyhalogenated aromatic hydrocarbons present in body fluids, such as serum and follicular fluid. To the best of our knowledge, this is the first investigation to determine TEQvaIues by the CALUX bioassay in follicular fluid. The TEQ levels in both matrices are well corrdated (r = 0.83, p = 0.02). As the chemical and bioassay analysis exected in this study do not cover the same span of polyhalogenated aromatic hydrocarbons, we did not expect totally correlated results. Moreover, the sample workup and quantification of the analytes difered completely. Nonetheless, the TEQ values in human extracts correlated well with the sum of four major PCB congeners chemically determined in both serum and follicular fluid. These results indicate that the CALUX bioassay may serve as a simple, relatively inexpensive prescreening tool for exposure assessment in epidemiologic surveys.
Polyhalogenated aromatic hydrocarbons (PHAHs) represent a class of widespread environmental contaminants including polychlorinated dibenzo-p-dioxins (PCDDs), polychlorinated dibenzofurans (PCDFs), and polychlorinated biphenyls (PCBs). Due to their low biodegradation and lipid solubility, these ubiquitous pollutants bioaccumulate throughout the food chain and may pose a health risk to both animals and humans (1) . In fact, several epidemiologic studies indicate subtle changes in neurobehavioral and endocrine parameters in infants in relation to relatively high background levels of PHAHs, which can occur in industrialized countries in the Western World (2, 3) .
Since 1970, body burden measurements for chlorinated contaminants in humans have been determined in blood, follicular fluid, human milk, and adipose tissue (4, 5) . Current techniques for detection and quantification of PHAHs involve costly and timeconsuming traditional chemical analysis by gas chromatography with mass spectrometry in selected ion monitoring or electron-capture detection mode. Gas chromatography analysis provides information about the presence and concentration of known isomers and congeners, but no information about the biologic effects of these complex mixtures (6) .
Extensive experimental studies have revealed that most toxic actions induced by dioxin-like compounds are mediated via the aryl hydrocarbon receptor (AhR) signal transduction pathway (7, 8) . Quantification of the toxic potency of the whole mixture of compounds acting via the AhR pathway would strengthen the causal relationship between observed adverse effect and the presence of PHAHs as a group (91. For this purpose, the dioxin-like toxic equivalency factor (TEF) concept was introduced by Safe (10) , allowing conversion of the PHAH chemical data set into the AhR-related toxic potency of the mixture of PHAHs. PCB congeners that can assume a coplanar configuration (non-ortho, and to a lesser extent some mono-ortho substituted congeners) also have a high affinity to the AhR (7, 11) . It has recently been shown that the contribution of dioxin-like PCBs to the total TEQ value in human matrices is almost equal to the PCDDs/PCDFs fraction (12, 13 (6, 14) . A vector containing the luciferase gene under transcriptional control of dioxin-responsive elements was stably transfected into a number of cell lines, including the rat H4IIE hepatoma cell line. The CALUX bioassay has recently been adapted and validated in blood plasma (9) and bovine milk (15) .
In this study, we assessed exposure to PHAHs using a combination of chemical and bioassay analysis in a selected female subpopulation. Major PCB congeners in serum and follicular fluid were quantified by chemical analysis using gas chromatography with electron-capture detection (GC-ECD) and TEQ values in blood serum were determined using the CALUX bioassay. Four PCB congeners, IUPAC (International Union of Pure and Applied Chemistry) numbers 118, 138, 153, and 180, were selected because many European government and regulatory bodies use them as marker compounds to monitor occurrence and distribution. In human matrices, the three latter congeners make up 55% of the total PCBs (16 was used with the following temperature program: initial 65°C held for 2 min, then to 220°C at a rate of 50°C/min, 1.5°C/min to 255°C, and then 20°C/min to 290°C, and held for 5 min. The carrier gas was hydrogen at a constant pressure of 135 kPa. The pECD temperature was kept at 320°C, using argon-methane (95 + 5) makeup gas at a flow rate of 20 mL/min. CALUX bioassay. The extraction and cleanup procedure was performed as described in detail by Murk et al. (9) . The method involves esssentially n-hexane extraction of blood serum or follicular fluid aliquots (1-1.5 mL) and removal of acidlabile matrix components by passage through a silica column containing 33% (w/w) concentrated H2S04. This extract was quantitatively transferred to a tapered vial, evaporated, and diluted in DMSO for CALUX measurement in 96-well plates using H4IIE.Luc cells.
Rat H4IIE hepatoma (H4L1.1c4) cells stably transfected with an AhR-controlled luciferase reporter gene construct (pGudlucl.1) were grown to confluence in 96-well view plates and exposed in triplicate to the PHAH samples and TCDD standards for 24 hr, using DMSO (0.5% v/v) as a vehicle. After removal of the medium, cells were washed twice with phosphate-buffered saline (Oxoid, Hampshire, UK). The cells were harvested in 75 jL cell lysis reagent and centrifuged, and the supernatant was frozen at -80°C. For measurement of luciferase activity, the supernatants were thawed on ice, 20-gL aliquots were pipetted into a 96-well microtiter plate, and 100 jL luciferin assay mix at room temperature was added. After thorough mixing, we measured the light production in a Luminoskan RS Luminometer (Labsystems, Helsinki, Finland).
Lipid determination. Lipids of serum and follicular fluid were determined enzymatically. Concentrations of triglycerides, cholesterol (free and cholesterol esters), and phospholipids were determined in duplicate by quantitative enzymatic determination using commercially available reagents from Elitech Diagnostics (Sees, France). We calculated the total serum lipid concentration by adding the amounts of triglycerides, cholesterol, and phospholipids. The total mean serum lipid concentration by enzymatic determination was 507 ± 122 mg/dL (n = 106, range 214-1,059). For the follicular fluids, the cholesterol and triglycerides could not be quantified enzymatically. Hence, the phospholipid contents were used for further calculations. The mean lipid concentration for follicular fluids was 49.2 ± 15.8 mg/dL (n = 9, range 23-72).
Calculations ofCALUX TEQs and statistics. We calculated CALUX-based TEQs by comparing the luciferase activity induced by the sample against a dose-response curve generated from TCDD concentration standards analyzed simultaneously. The standard curve was fitted (one-site ligand fit) using SlideWrite 6.00 (Advanced Graphics Software Inc., Encinitas, CA), and the CALUX TEQ value of an unknown sample was interpolated on this curve. A full dose-response curve was presented previously (20) . Mean values were calculated from the individual TEQ/g fat values thus obtained from each of three replicates.
All statistical calculations were performed using Statistica (version 5; StatSoft, Tulsa, OK). Means, SDs, and medians are reported in terms of original distributions. All the variables were tested for normality by Shapiro- To compare the PCB accumulation pattern in follicular fluid and serum, the total sum of all four congeners has been taken as 100%, and this distribution is presented in Figure 1 . Follicular fluid and serum show opposite patterns of accumulation for PCB-153 and PCB-180. PCB-153 is the major congener in serum, in contrast to the follicular fluid, where PCB-180 is considerably more concentrated.
TEQ values measured through the CALUX bioassay are summarized in Table  2 . The results of 14 serum samples and 1 follicular fluid sample were below the limit of detection (32 fg TEQ/well). The mean TEQ level in follicular fluid is considerably higher than the mean serum TEQ value (257.9 ± 225.0 and 46.8 ± 43.8 pg TEQ/g lipid, respectively, in follicular fluid and serum), partly due to the lower fat content of the follicular fluid. However, the correlation between TEQ levels in serum and follicular fluid is statistically significant (n = 7, r = 0.83, p = 0.02). The high coefficients of variance are partly due to the small numbers (follicular fluid and plasma) and partly due to a wide variation of contamination in these selected subpopulations.
Comparison between CALUX TEQ values and PCB levels. The Pearson correlation coefficients between the CALUX TEQ values and the nonplanar PCB congeners within the serum samples are all highly significant and vary from 0.34 to 0.43 (Table 3 ). In addition, the correlation coefficients in follicular fluid are up to 0.74 for the PCB congeners. The correlation is statistically significant for PCB-138. The distributions of the sum of PCB congeners and TEQ levels in serum are shown in Figure 2A and 2B, respectively. Both skew distributions show a median level lower than the mean concentration.
Comparison of TEQ levels with other CALUX data. In 1989, a collaborative study was started in The Netherlands (Dutch Mother's Milk Cohort Study); this study concerning the potential effects of PCBs and dioxins on the growth and development of newborns (21) (22) (23) (24) . Because dioxinlike compounds normally exist in environmental and biologic samples as complex mixtures of congeners, the concept of TEQs has been introduced to simplify risk assessment and regulatory control. In applying this concept, relative toxicities of dioxin-like compounds in relation to TCDD (i.e., TEFs) are determined based on in vitro and in vivo studies (11) . Previously, TEQs were determined using gas chromatography with high-resolution mass spectrometry (GC-HRMS) for the chemical analysis. Although this approach is an improvement over simple chemical analysis, the often small concentrations of individual congeners, the presence of unknown or not routinely measured AhR-active substances, the lack of TEF values for several PHAHs, and the possible additive and/or antagonistic interactions between PHAHs (1,11) are drawbacks to this GC-HRMS analysis (9) . These pitfalls are overcome by the immediate measurement of the biologic response instead of determining the culprit compounds using chemical analysis. This alternative technique using the CALUX bioassay determines the TEQ value as a sum of the synergistic, additive, or antagonistic interactions ofall AhR-active compounds.
In this survey, exposure assessment to dioxin-like compounds was performed using gas chromatography to quantify PCB congener levels and the CALUX bioassay, which We previously evaluated the relationship between gravimetric and enzymatic lipid determinations (25) . The correlation for serum lipids was strong and statistically significant (r = 0.75, n = 96, p < 0.001); however, gravimetric lipid determinations differ greatly between laboratories, depending on the extraction conditions and solvents used. Moreover, the extracts can contain other extractable material as well ($).
PCB-153 and PCB-180 do not possess two unsubstituted carbohydrons next to each other and are therefore highly persistent in the environment. In the same way, highly chlorinated biphenyls containing a 2,3,4-trichlorophenyl group (such as PCB-138) can resist metabolic breakdown and so accumulate rapidly in body tissues (26) . We previously reported that serum concentrations of major PCB congeners are reliable predictors of follicular fluid levels (27) . Except for PCB-1 18, the major PCB congener correlations were strong and statistically significant. (1990) (1991) (1992) ; lipids gravimetrically determined. cDetection limit 32 fg TEO/well. Figure 2 . Distribution of (A) the sum of four PCB congeners and (B) CALUX TEQ levels in serum (n = 106).
In (8), 14 observations are not shown due to TEQ levels below the detection limit.
All these results were expressed on a wholeweight basis. Focusing on our recent data (Table 1) , the previous associations can be confirmed (12. 
